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Abstract
Background: Osteochondral allograft transplantation has a good clinical outcome, however, there is still debate
on optimization of allograft storage protocol. Storage temperature and nutrient medium composition are the
most critical factors for sustained biological activity of grafts before implantation. In this study, we performed a
time-dependent in vitro experiment to investigate the effect of various storage conditions on electromechanical,
histological and histochemical properties of articular cartilage.
Methods: Osteochondral grafts derived from goat femoral condyles were frozen at −70 °C or stored at 4 °C and
37 °C in the medium supplemented with or without insulin-like growth factor-1 (IGF-1). After 14 and 28 days the
cartilage samples were quantitatively analysed for electromechanical properties, glycosaminoglycan distribution,
histological structure, chondrocyte viability and apoptosis. The results were compared between the experimental
groups and correlations among different evaluation methods were determined.
Results: Storage at −70 °C and 37 °C significantly deteriorated cartilage electromechanical, histological and
histochemical properties. Storage at 4 °C maintained the electromechanical quantitative parameter (QP) and
glycosaminoglycan expression near the normal levels for 14 days. Although hypothermic storage revealed reduced
chondrocyte viability and increased apoptosis, these parameters were superior compared with the storage
at −70 °C and 37 °C. IGF-1 supplementation improved the electromechanical QP, chondrocyte viability and
histological properties at 37 °C, but the effect lasted only 14 days. Electromechanical properties correlated with
the histological grading score (r = 0.673, p < 0.001), chondrocyte viability (r = −0.654, p < 0.001) and apoptosis
(r = 0.416, p < 0.02). In addition, apoptosis correlated with glycosaminoglycan distribution (r = −0.644, p < 0.001) and
the histological grading score (r = 0.493, p = 0.006).
Conclusions: Our results indicate that quality of allografts is better preserved at currently established 4 °C storage
temperature. Storage at −70 °C or at 37 °C is unable to maintain cartilage function and metabolic activity. IGF-1
supplementation at 37 °C can enhance chondrocyte viability and improve electromechanical and histological
properties of the cartilage, but the impact persists only 14 days. The correlations between cartilage electromechanical
quantitative parameter (QP) and metabolic activity were detected. Our findings indicate that non-destructive
assessment of cartilage by Arthro-BST is a simple and reliable method to evaluate allograft quality, and could be
routinely used before implantation.
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Background
Articular cartilage injury is a frequent incidental finding
during knee arthroscopic surgery [1, 2]. Large osteo-
chondral defects in the knee joint present a very big
challenge to the orthopaedic surgeons and remain an
important risk factor for osteoarthritis development.
Among numerous treatment options currently available
in clinical practice, osteochondral transplantation is the
only biological technique that can anatomically and
functionally restore the hyaline cartilage [3–9]. Autolo-
gous osteochondral transplantation has demonstrated
good to excellent clinical results [10–13], however, its
use is limited due to the lack of healthy cartilage tissue
and related donor site morbidity [14, 15].
Cartilage is avascular, aneural and relatively immuno-
privileged tissue populated with chondrocytes residing
within the extracellular matrix, thus, making it attractive
for allogeneic transplantation [16, 17]. Efficacy of osteo-
chondral allograft transplantation (OCA) has already
been previously established [18–25]. However, its applica-
tion is limited by the need for infectious disease screening,
which requires extended allograft storage [26, 27]. Long-
term in vitro maintenance of osteochondral allograft tissue
poses a very big challenge, especially for cell viability.
Chondrocyte viability is a major determinant of graft per-
formance in vivo. Implantation of viable chondrocytes can
assure prolonged maintenance of the extracellular matrix
and integrity of the articular cartilage after transplantation.
Despite numerous studies on allograft preparation, storage
conditions and already approved protocols used by tissue
banks, research on how to maintain viable cells is still on-
going [18, 28]. Several studies have shown that deep freez-
ing and cryopreservation leads to plummeted chondrocyte
viability [29–31]. Hypothermic storage at 4 °C, currently
used by most tissue banks, has been shown capable of
maintaining chondrocyte viability and matrix integrity
[32–34]. Recently allograft storage at 37 °C has been pro-
posed, because superior results in comparison with re-
frigeration have been reported [29, 35].
Different storage media compositions have been used to
improve chondrocyte survival during allograft storage.
Serum-free medium [19, 35, 36], fetal bovine serum (FBS)
supplemented medium [29, 37], dexamethasone [38], eta-
nercept [39] and platelet-rich plasma [40–42] have been
used with varying success. Insulin-like growth factor-1
(IGF-1) is also considered to be a viable treatment option
for osteochondral injuries. IGF-1 stimulates chondrocyte
proliferation and synthesis of the extracellular matrix, and
is chondroreparative [42, 43]. These studies suggest a po-
tential role of different biological regulators in cartilage re-
pair, however, their appropriate dosing and impact on
chondrocyte metabolic activity is unknown.
Research has shown that apoptosis or programmed
cell death is crucial for maintaining the appropriate
number of cells and tissue organization. Chondrocyte
death by apoptosis has been linked with cartilage matrix
degradation and initiation of osteoarthritic lesions [44, 45].
A substantial relationship between inhibition of chondro-
cyte apoptosis and improved chondrocyte viability during
cold storage of osteochondral grafts has been demon-
strated [46]. This study suggested that the apoptotic
process could be manipulated to enhance chondrocyte sur-
vival and improve the results of osteochondral allograft
transplantation. Robertson et al. have studied apoptotic
gene expression in stored osteochondral allografts and
found many apoptotic genes with prolonged storage [47].
Recently, a new technology has been employed to as-
sess functional properties of the cartilage. Arthro-BST,
an arthroscopic device, enables measurement of cartilage
streaming potentials, which have been emphasized as an
important parameter of cell and matrix viability [48].
Streaming potentials reflect cartilage composition and
function, and are sensitive to degradative changes. It has
been shown that the electromechanical measurements ob-
tained with arthro-BST correlate with histological scores
and biomechanical parameters, and provide rapid and reli-
able assessment of articular cartilage damage [49].
Progress in tissue transplantation, increased availability
of fresh donor tissue, and greater demand, especially in
athletic and aging population, may explain the growing
need for allograft tarnsplantation procedures, which
speed up recovery and help return to sports, or postpone
arthroplasty for the elderly. However, the lack of clinical
evidence on best preservation conditions for OCA re-
quires more investigation on retaining chondrocyte via-
bility and cartilage matrix integrity during allograft
screening. Different storage conditions have to be re-
evaluated and an optimal allograft tissue storage proto-
col must then be proposed.
The purpose of this study was to assess electromech-
anical, histological and histochemical properties of ar-
ticular cartilage after allograft storage for 14 and 28 days
at −70 °C, 4 °C and 37 °C, and investigate the effect of IGF-
1 supplementation at 4 °C and 37 °C. Secondarily, we aimed
to examine the relationship between cartilage streaming po-
tentials, measured by Arthro-BST device, and chondrocyte
viability, apoptosis and histological evaluation.
Methods
Osteochondral graft preparation and storage
All experiments were approved by the Animal Health
and Welfare Department, State Food and Veterinary
Service. Osteochondral plugs, consisting of articular car-
tilage and subchondral bone (5 mm diameter), were har-
vested from medial femoral condyles of six 5 to 6-month
old male Saanen goats using standard OATS technique
(Arthrex Inc, USA) under sterile conditions. The sam-
ples were rinsed with phosphate-buffered saline (PBS;
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Sigma) supplemented with 100 U/mL penicillin, 100 μg/mL
streptomycin and 0.25 μg/mL fungizone (PSF) (Sigma), and
randomly allocated to the following groups (n = 6 in
each group): freshly harvested control (Fresh), frozen
at −70 °C (−70 °C), refrigerated at 4 °C in 100 % at-
mospheric air (4 °C), and incubated at 37 °C (95 %
humidity, 5 % CO2) (37 °C). The samples from 4 °C and
37 °C groups were placed in 24-well plates containing low
glucose Dulbecco's Modified Eagle's Medium (DMEM)
(Sigma), supplemented with 10 % fetal bovine serum
(FBS) (Sigma), 1 % of PSF), 2 mM L-glutamine (Sigma),
25 μg/mL L-ascorbic acid (Sigma), and 0.1 mM MEM
non-essential amino acids solution (Sigma) with or with-
out 100 ng/mL of IGF-1(Sigma). The samples were stored
for 14 or 28 days. At the end of storage period, the osteo-
chondral plugs were first analyzed for electromechanical
properties, and then cut in half and subjected to further
processing for evaluation of chondrocyte viability, apop-
tosis, glycosaminoglycan expression and histological scor-
ing. The freshly harvested control samples were analyzed
on the same day after collection (Fig. 1).
Electromechanical measurements
The electromechanical properties of the samples stored
at different temperatures and nutritive medium condi-
tions were evaluated with Arthro-BST™ (Biomomentum
Inc., Laval, QC, Canada). The Arthro-BST is a relatively
new medical device for non-destructive evaluation of ar-
ticular cartilage electromechanical properties. The hand-
held hemispherical indenter containing an array of 37
gold microelectrodes (5 microelectrodes/mm2) records
streaming potentials in the articular cartilage generated
during gentle compression. During compression positive
mobile ions in the interstitial fluid are displaced relative
to the fixed negatively charged proteoglycan molecules,
which are entrapped in the collagen network creating nor-
mal streaming potentials. In degenerated cartilage the net-
work of collagen and proteoglycans is degraded leading to
very low streaming potentials. A quantitative parameter
(QP, arbitrary units), calculated by the computer software,
corresponds to the number of microelectrodes in contact
with the cartilage when the sum of streaming potentials
reaches 100 mV. High QP indicates high compliance and,
therefore, weak electromechanical properties reflecting
poor load-bearing capacity of the cartilage. On the con-
trary, low QP indicates strong electromechanical proper-
ties and high load-bearing capacity [49]. Prior to testing,
the ostochondral grafts were immersed in PBS solution
for 20 min and the QP of each graft was recorded 5 times
in order to obtain median values.
Detection of chondrocyte viability
Chondrocyte viability was analyzed using LIVE/DEAD®
assay (Molecular Probes, Eugene, OR, USA) staining and
confocal microscopy. The samples were washed in PBS
and then labelled with 1 μM calcein AM (to detect live
cells) and 2 μM ethidium homodimer-1 (to detect dead
cells). Thereafter, the samples were incubated for 40 min
at 37 °C, washed 3 times in PBS for 10 min and proc-
essed for imaging. 200 μm thick slices were imaged
along the vertical profile with inverted confocal micro-
scope LSM 700 Axio Observer Z.1 (Carl Zeiss,
Germany). Image stacks, consisting of 8 slices each at
0.74 μm interval were obtained at 20x magnification.
Live and dead cells were counted in 2 random areas
(200 × 400 μm) in each tissue section using Image J ver-
sion 1.47q (National Institutes of Health, Bethesda, MD,
USA). Chondrocyte viability was calculated as a percent-
age of live cells relative to the total cell number.
Histological evaluation
The samples were fixed in 10 % neutral buffered forma-
lin, decalcified in Shandon TBD-2 Decalcifier (TBD;
Thermo Scientific, Kalamazoo, MI, USA) and embedded
in paraffin. Cartilage sections (5 μm thick) were stained
with safranin O-fast green using an established protocol
[50] to detect the glycosaminoglycan (GAG) positive
matrix that is typical for the hyaline cartilage and nor-
mally stains red. Light microscopy images were taken at
4× magnification with Olympus BX63 microscope
(Olympus, Japan) equipped with Olympus DP72 CCD
camera using CellSens Dimension imaging software
(Olympus, Japan). The images were analysed using
Image J software. Previously described image processing
protocol was adapted to quantify the amount of GAG
distribution in each section [51]. Briefly, red colour in-
tensity (RCI) was calculated in the entire cross-sectional
slice area by obtaining red, green, and blue (RGB) image
planes in a scale of 256 values (black = 0). The fraction
of red (RF) was defined as the ratio of the R component
to the sum of the R, G, and B components: RF = R/(R +
G + B) and expressed as a percentage. Sections were
additionally evaluated by 3 blinded observers using
histological-histochemical grading system proposed by
Mankin et al. [52]. Fresh articular cartilage received the
score of 0, whereas higher score indicated more deterio-
rated cartilage.
TUNEL assay for chondrocyte apoptosis
Apoptosis was evaluated with TUNEL assay kit (ApopTag®
Peroxidase In Situ Apoptosis Detection Kit; Millipore,
USA) using the protocol provided by the manufacturer.
Briefly, deparaffinised tissue sections were incubated in
20 μg/mL Proteinase K (Ambion) for 15 min at room
temperature. After endogenous peroxidase has been
quenched by incubation in 3 % hydrogen peroxide for
5 min, the ends of fragmented DNA in the tissue were la-
belled with terminal deoxynucleotidyl transferase (TdT)
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enzyme in the presence of digoxigenin-conjugated nucleo-
tides and unlabeled nucleotides for 60 min in humidified
chamber at 37 °C. The slides were then incubated for
30 min with anti-digoxigenin antibodies conjugated to a
peroxidase reporter molecule. Immunohistochemical de-
tection of these antibodies was carried out by exposure to
a chromogenic DAB substrate (Sigma) for 10 min. The
slides were counterstained with Methyl Green (Sigma) so-
lution for 5 min, rinsed in distilled water, dehydrated in al-
cohol, cleared in xylenes, and mounted with cytoseal
under a coverglass.
High magnification images (200×) were obtained with
Olympus BX63 microscope (Olympus, Japan). The num-
ber of apoptotic (brown-black) and viable (green) cells
was counted in 3 random areas (200 × 400 μm) selected
in two tissue sections from each sample. The percentage
of apoptotic cells was then calculated.
Statistical analyses
The data were analyzed using the SPSS v.19. All results
are presented as the mean ± standard deviation. Statistical
differences between the sample groups were assessed
using one-way repeated measures analysis of variance
(ANOVA) with Bonferroni post hoc multiple comparison
test. p < 0.05 was considered statistically significant. The
relationship between the QP, chondrocyte viability, apop-
tosis, GAG distribution and histological grading scores
was assessed by nonparametric correlation analysis using
Fig. 1 Sketch of the experimental setup. a The design of experimental setting showing different allograft storage conditions and evaluation time
points. b, c In vitro evaluation of the graft electromechanical properties with Arthro-BST
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Spearman‘s correlation coefficient. A significant correl-
ation was present when p < 0.05.
Results
Electromechanical properties of osteochondral grafts
The QP of the freshly harvested samples on average was
4 ± 0.23 (Fig. 2). We observed significantly increased QP
after 14 days for the samples stored at −70 °C or incubated
in DMEM at 37 °C (5.6 ± 0.49 and 5.57 ± 0.43, respect-
ively; p < 0.001). For the samples stored in DMEM at 4 °C,
we detected a slightly increased QP (4.43 ± 0.15), however,
QP was significantly lower compared to both aforemen-
tioned groups (p < 0.001). When the culture medium was
supplemented with IGF-1, there was a slight increase of
QP for the grafts stored at 4 °C (4.53 ± 0.27), however, a
considerable decrease of QP was detected for the grafts
stored at 37 °C (4.77 ± 0.32; p = 0.043).
After 28 days of storage, electromechanical properties of
the samples worsened. For the samples stored at −70 °C,
only a slight increase of QP (5.93 ± 0.33) was detected. For
the grafts incubated in DMEM at 37 °C, we observed a
significant increase of QP (6.63 ± 0.34; p = 0.001) when
compared to 14-day storage period. Although there
was a diminutive increase of QP in the refrigeration
group (5.17 ± 0.34), it was significantly lower com-
pared to the incubation at 37 °C group (p < 0.001).
The addition of IGF-1 to the culture medium at this
time had no significant effect on QP at 4 °C and 37 °C.
These findings clearly indicate that allograft refrigeration
has a greater capacity of preserving electromechanical
properties of the osteochondral grafts compared to freez-
ing or incubation at 37 °C and could prevent rapid deteri-
oration of the cartilage.
Chondrocyte viability
Chondrocyte viability for the freshly harvested articular
cartilage was approximately 83.3 ± 2.98 % (Fig. 3a, b).
We detected a significant decrease of chondrocyte viability
in all the storage groups after 14 and 28 days (p < 0.001)
compared to fresh cartilage samples. The samples stored
at −70 °C contained smallest amount of viable chondro-
cytes compared with any other storage group. After
14 days, the −70 °C samples contained only 35.2 ± 6.9 % of
viable chondrocytes, whereas samples stored in DMEM
medium at 37 °C contained 44.87 ± 4.53 % of viable chon-
drocytes. No significant difference was detected between
these two groups. For the samples stored in DMEM
at 4 °C, viability was 58.22 ± 4.07 % and it was signifi-
cantly higher compared with the −70 °C and 37 °C
storage groups (p < 0.001 and p < 0.003, respectively).
When IGF-1 was added to the medium, chondrocyte
viability decreased in the 4 °C storage group (53.89 ±
6.48 %) and increased in the 37 °C storage group
(49.22 ± 7.35 %), but this change was not significant.
After 28 days, the samples stored at −70 °C contained
significantly less viable chondrocytes (35.46 ± 4.36 %)
compared with any other storage group (p ≤ 0.001).
There was no significant difference in chondrocyte via-
bility between the samples stored at 37 °C and 4 °C
(52.02 ± 5.97 % and 57.80 ± 2.71 %, respectively). When
IGF-1-supplemented medium was used, chondrocyte
viability slightly decreased in the 4 °C and 37 °C groups
(53.81 ± 4.90 % and 49.93 ± 4.96 %, respectively). These
results suggest that storage at −70 °C is unable to main-
tain chondrocyte viability. Storage at 4 °C is capable of
maintaining significantly higher chondrocyte viability
than storage at 37 °C, but this effect lasts only 2 weeks.
Fig. 2 Electromechanical properties of osteochondral samples, as analyzed by Arthro-BST. Electromechanical properties of samples stored in different
temperature and nutritive medium conditions were evaluated after 14 and 28 days. Freshly harvested cartilage was used as control. Quantitative
parameter (QP) measurements are presented as arbitrary units (mean ± standard deviation). *p < 0.001 (fresh versus −70 °C and 37 °C group after
14 days, and versus all other groups after 28 days); **p < 0.001; #p < 0.05
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IGF-1 supplementation increased chondrocyte viability
at 37 °C during 14-day storage, but did not reveal a pro-
found effect at any time at 4 °C and 37 °C after 28 days.
GAG quantification by safranin O staining
Cartilage sections from all sample groups were stained
with safranin O-fast green and evaluated for GAG distri-
bution (Fig. 4a). Red colour intensity (RCI) of the freshly
extracted normal articular cartilage was 72.95 ± 1.06 %
(Fig. 4b). We observed a significant reduction of RCI after
storage at −70 °C for 14 days (61.50 ± 9.60 %; p = 0.018).
RCI of samples stored in DMEM at 4 °C remained very
close to a fresh cartilage level 71.48 ± 5.61 %. When IGF1
was added to the medium at 4 °C RCI decreased to
62.58 ± 9.57 %, but this change was not significant.
For the samples stored in DMEM at 37 °C, we observed a
significant reduction of RCI compared with the fresh and
refrigerated samples (54.4 ± 1.76 %; p ≤ 0.001). When IGF-
1 was added to the medium at 37 °C, RCI increased to
63.98 ± 9.35 %, but this increase was not significant. After
28 days, RCI for all the samples was significantly lower
compared with the fresh samples and constituted 57.89 ±
2.31 %, 59.02 ± 5.46 % and 48.58 ± 3.43 %, for −70 °C, 4 °C
and 37 °C storage groups, respectively (p < 0.002). A
significant reduction of RCI compared with a 14-day stor-
age period was detected in the samples stored in DMEM
at 4 °C (p = 0.078). When IGF-1 was added to the storage
medium at 4 °C and 37 °C, RCI decreased to 54.12 ±
7.27 % and 45.91 ± 4.1 %, respectively. There was no statis-
tically significant difference between the groups after
Fig. 3 Chondrocyte viability in osteochondral samples, as analyzed by LIVE/DEAD® fluorescence staining. a Confocal microscopy images showing
abundance of live cells (green) in fresh cartilage and increased population of dead cells (red) after 14 and 28 days of storage in different conditions.
Scale bar = 100 μm. b Chondrocyte viability was calculated as a percentage of live cells to the total number of cells (mean ± standard deviation).
*p≤ 0.001 (fresh versus all other groups after 14 and 28 days); **p < 0.001; ***p = 0.003; #p≤ 0.001(−70 °C group versus all other groups after 28 days)
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28 days. These results indicate that allograft storage
at 4 °C maintains GAG distribution near the normal
levels for 14 days and is superior compared with stor-
age at 37 °C. IGF-1 supplementation did not help to
maintain GAG distribution at 4 °C, but facilitated
these properties at 37 °C. However, during extended
storage GAG distribution decreased and there was no
significant difference between the groups.
Histological grading
We also analyzed whether different storage conditions
had effect on histopathology. We used the histological-
histochemical grading system proposed by Mankin et al.
[52]. Even though this method is intended to be used for
the grading of the human osteoarthritic cartilage, it has
also been used in animal studies [53, 54]. After 14 days,
the samples stored at −70 °C and 4 °C exhibited slightly
reduced safranin O staining with diffuse hypercellularity
at the superficial cartilage layer and received the scores
of 1.83 ± 0.75 and 1.4 ± 0.89, respectively (Fig. 4c). In
contrast, the samples stored at 37 °C received a score of
3.2 ± 0.84 because of structural irregularities, hypocellu-
larity and clonal cells, which were accompanied by a
slight reduction in safranin O staining throughout the
superficial and middle layer of the cartilage. In addition,
the histological score in the 37 °C group was significantly
higher (p = 0.019) compared with the 4 °C group, indicat-
ing more rapid cartilage deterioration. The histological
scores after 28 days increased in each group. The samples
stored at 37 °C received significantly higher scores com-
pared with the −70 °C and 4 °C groups (4.33 ± 0.82 versus
2.0 ± 0.82 and 2.5 ± 0.55, respectively; p = 0.005), as was
evident by a more diffuse hypercellularity and markedly
reduced safranin O staining throughout the samples.
IGF-1 addition to the medium at 4 °C and 37 °C had
no profound effect on the histological scores compared
Fig. 4 GAG distribution in osteochondral samples, as analyzed by Safranin O-Fast Green staining, and histological–histochemical grading according to
Mankin. a Histological images of fresh cartilage and after 14 and 28 days of storage in different conditions. Scale bar = 1 mm. b Quantitative analysis of
GAG distribution by red color intensity (RCI) using an adapted image processing protocol. All samples revealed significantly reduced RCI after 28 days
of storage. *p < 0.002 (fresh versus all other groups after 28 days); **p < 0.02; ***p≤ 0.001 (c) Histological-histochemical grading scores. Fresh cartilage
was assigned with the score of 0, while higher score indicates cartilage deterioration. ##p < 0.02; #p = 0.005
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with DMEM alone after 14 days of storage, although a
slight improvement was detected at 37 °C. Higher histo-
logical scores were observed after 28 days, but signifi-
cant increase compared with the 14-day period was
detected only in the 37 °C group (p < 0.001) after IGF-1
supplementation. Increased diffuse hypercellularity was
evident in both IGF-1 supplemented groups after pro-
longed storage. In addition, inferior surface structure,
moderate to severe reduction in safranin O staining and
clonal cellularity with hypocellular areas were notable
throughout the 37 °C samples after 28 days of storage.
Chondrocyte apoptosis
The extent of chondrocyte apoptosis varied among dif-
ferent storage groups. The freshly harvested samples
contained on average 54.55 ± 8.87 % of TUNEL positive
chondrocytes (Fig. 5). After 14 days, a significant in-
crease in apoptotic chondrocyte number was observed
at −70 °C and 37 °C (85.82 ± 8.72 % and 93.91 ± 1.1 %,
respectively; p < 0.001). Albeit it was a significant
increase in the 4 °C group (74.98 ± 8.67 %; p = 0.021),
this group contained considerably less (p = 0.015) apop-
totic chondrocytes compared with the 37 °C storage
group. IGF-1 supplementation had no profound effect
on apoptosis at 4 °C and 37 °C.
After 28 days, the percentage of apoptotic chondrocytes
in each group did not change significantly when compared
with the 14-day storage. Yet again, we detected signifi-
cantly less apoptotic chondrocytes in the refrigeration
group compared with the 37 °C storage group (74.39 ±
3.60 % and 94.32 ± 1.90 %, respectively; p = 0.008). IGF-1
addition at this time also did not altered apoptosis at 4 °C
and 37 °C. These findings indicate that allograft storage at
4 °C is associated with a lesser extent of apoptosis than
storage at 37 °C. IGF-1 had no impact on chondrocyte
apoptosis in any group at any time.
Correlations between different quantitative parameters
The statistical analysis revealed that the electromechanical
QP correlated directly with the histological grading score
Fig. 5 Chondrocyte apoptosis in osteochondral samples, as analyzed by TUNEL immunoassay to detec apoptotic cells. a Light microscopy images
showing abundance of viable cells (green) in fresh cartilage and increased population of apoptotic cells (brown-black) after 14 and 28 days of
storage in different conditions. Scale bar = 50 μm. b The percentage of apoptotic cells was calculated as the number of apoptotic cells related to
the total number of cells. Apoptosis significantly increased throughout different storage groups. *p < 0.001 (fresh versus all other groups, except
4 °C after 14 and 28 days); #p < 0.05 (fresh versus 4 °C after 14 and 28 days); **p = 0.008
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(r = 0.673, p < 0.001), apoptotic chondrocytes (r = 0.416,
p = 0.018), and inversely with chondrocyte viability
(r = −0.654, p < 0.001) (Fig. 6). In addition, the extent
of apoptosis correlated directly with the histological
grading score (r = 0.493, p = 0.006) and inversely with
GAG distribution manifested by RCI measurement
(r = −0.644, p < 0.001)
Discussion
Our results demonstrate that the cartilage samples
stored at 4 °C possessed higher chondrocyte viability and
GAG distribution, lower apoptosis and nearly normal
electromechanical properties compared with the samples
stored at 37 °C. These improvements were apparent
throughout 28 days. However, there was no significant
difference in chondrocyte viability and GAG expression
between two groups after 28 days. Our results did not
support previous studies which indicate that allograft
storage at 37 °C is superior to storage at 4 °C. Garrity
et al. found that osteochondral allograft viability, matrix
content, composition and biomechanical properties were
maintained at ‘fresh’ levels through 56 days of storage in
the standard medium at 37 °C, but allografts stored at
4 °C were unable to maintain viability or matrix integrity
through 28 days of storage [35]. In distinction to the lat-
ter study, which used a serum-free medium, we used
10 % FBS-supplemented medium. Numerous studies
have demonstrated that addition of FBS to the nutrient
media can significantly increase chondrocyte survival
during storage at 4 °C [32, 37, 43]. Pallante et al. re-
ported that chondrocyte viability was higher after stor-
age at 37 °C, instead of 4 °C, while cartilage thickness,
GAG and collagen content were maintained at both
temperatures [29]. In that study 4 °C samples were
stored in 10 % FBS-supplemented medium pre-
equilibrated to 5 % CO2 and tightly sealed. By contrast,
in this study the specimens were stored in 24-well plates
exposed to 100 % atmospheric air with medium change
three times per week. Prior studies have also suggested
that replenishment of nutrients by regular changes of
the medium may enhance chondrocyte survival in
hypothermically stored cartilage specimens [32, 55].
We also detected that storage at −70 °C was associated
with significant decline in chondrocyte viability and
Fig. 6 Correlations between different quantitative parameters. Bivariate linear correlations were assessed using Spearman‘s correlation coefficient.
a Inverse correlation between chondrocyte viability (%) and quantitative parameter (QP). Correlation coefficient (r = −0.654), corresponding
P-value (p < 0.01); (b) Direct correlation between Mankin score and QP. Correlation coefficient (r = 0.673), corresponding P-value (p < 0.01); (c)
Direct correlation between apoptotic chondrocytes (%) and QP. Correlation coefficient (r = 0.416), corresponding P-value (p < 0.01); (d) Direct
correlation between Mankin score and apoptotic chondrocytes (%). Correlation coefficient (r = 0.493), corresponding P-value (p < 0.01); (e) Inverse
correlation between red color intensity (%) and apoptotic chondrocytes (%). Correlation coefficient (r = −0.644), corresponding P-value (p < 0.01)
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worse electromechanical properties compared to storage
at 4 °C. These results support previous findings that deep
freezing leads to dramatic loss of viable chondrocytes [29].
In fact, our results conflict previous findings that storage
at −80 °C does not change the mechanical properties of
articular cartilage [19, 55–57]. Even though we did not as-
sess biomechanical properties of the grafts, recent studies
demonstrated significant correlation between electro-
mechanical and biomechanical parameters [49, 58].
There is a limited number of studies that have investi-
gated the IGF-1 effect on chondrocyte viability during
allograft storage. Teng et al. [43] used a serum-free
medium at 4 °C and reported that viability after 3 weeks
was significantly higher in DMEM+ IGF-1 group com-
pared with DMEM alone group. However, after 4 weeks
researchers observed near a 10-fold decrease in the
DMEM+ IGF-1 group compared with a 2-fold decrease
in the DMEM alone group. Several reports have indi-
cated that IGF-1 can decrease chondrocyte apoptosis
induced by traumatic compression or collagenases treat-
ment [59, 60]. In this study the addition of IGF-1 to
DMEM at 4 °C did not produce a favourable effect on
chondrocyte viability, apoptosis and GAG distribution,
but the electromechanical properties in both groups
were quite similar and remained near normal levels after
14 and 28 days. Interestingly, it was found that IGF-1
supplementation at 37 °C had a positive effect on chon-
drocyte viability, GAG distribution and significantly im-
proved the electromechanical QP. However, these
improvements lasted only for 14 days and eventually,
after 28 days, all the parameters became worse com-
pared with the samples stored in DMEM without IGF-1.
Non-destructive evaluation of electromechanical prop-
erties by Arthro-BST is a relatively new technique in
cartilage research and it has already been shown very
useful for quantitative assessment of functional proper-
ties in cartilage repair studies [48, 49, 58]. It has been re-
ported that electromechanical measurements reflect
cartilage material properties and are even more sensitive
to the changes than biomechanical testing [58]. Al-
though we did not detect correlation between electro-
mechanical QP and GAG distribution (p = 0.059), our
findings are consistent with other studies demonstrating
that the electromechanical QP correlated directly with
the Mankin score [49, 61]. Cartilage cellular impair-
ment and subsequent reduction of safranin-O staining
was reflected by increased QP values. In addition, it
was observed that the electromechanical properties
correlated with the chondrocyte viability and apop-
tosis as reflected by relatioship between higher QP,
reduced viability and increased apoptosis. To our
knowledge, this is the first report when electromech-
anical properties of the articular cartilage were linked
with these biological parameters.
It has been reported that chondrocyte death by apoptosis
is closely associated with cartilage matrix degradation
which is crucial for osteoarthritis development [44]. De-
creased cell viability and increased apoptosis was also de-
tected after a traumatic joint injury [62]. Although we did
not observe correletion between viability and apop-
tosis (p = 0.051), we found that apoptosis correlated
directly with Mankin score and inversely with proteo-
glycan distribution as assessed by safranin-O staining.
These findings are consistent with previous reports
indicating significant linear relationship between the
histopathological grade of cartilage and chondrocyte
apoptosis [44, 63, 64].
One limitation of this study could be relatively small
number of samples per experimental group. However,
only one subjective parameter of histological grading
and four quantitative evaluation parameters used in our
study confirm reliability of the obtained data. In fact, the
correlation analyses performed at each designated time-
point revealed similar relationship between aforemen-
tioned parameters after 14 and 28 days. To further
investigate correlations between different storage groups
more samples would be required. Another limitation re-
lated to our study was previously descibed by Sim et al.
[49]. Although this study found no correlation between
electromechanical QP and human cartilage thickness,
authors indicated that it could be difficult to distinquish
high electromechanical properties of the cartilage for
low QP (<4) due to the geometry of Arthro-BST in-
denter and its limitations for thin cartilage. Regardless
the fact that the goat knee articular cartilage is substan-
tialy thinner compared to human [65], like in their
study, this limitation caused no problem for us since the
lowest average QP was 4.
Conclusions
Our results indicate that the quality of stored allografts
is better preserved at currently established refrigeration
temperatures compared with the storage at very low
temperatures or incubation at 37 °C. IGF-1 supplementa-
tion at 37 °C can enhance chondrocyte viability, improve
electromechanical and histological properties of the cartil-
age, but the effect is diminished beyond 14 days. The non-
destructive evaluation of cartilage by the Arthro-BST
enables a rapid, convenient and reliable way to estimate
allograft quality before implantation and warrants ordinary
use of this device in assessing articular cartilage damage
during arthroscopic surgery. In addition, this method could
provide precise information regarding efficacy of surgical
cartilage repair and is a promising technique for monitoring
the outcome of regenerative processes.
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